RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
This version was published on 1 January 2009
Ann Clin Biochem 2009;46:24-32
doi:10.1258/acb.2008.008094
© 2009 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
acb.2008.008094v1
46/1/24    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadfield, S G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Original Articles

Family tracing to identify patients with Familial Hypercholesterolaemia: the second Audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project

S G Hadfield1, S Horara1, B J Starr1, S Yazdgerdi1, D Marks2, D Bhatnagar3, R Cramb4, S Egan5, R Everdell5, G Ferns6, A Jones7, C B Marenah8, J Marples9, P Prinsloo8, A Sneyd8, M F Stewart10, L Sandle11, T Wang6,12, M S Watson6, S E Humphries13 on behalf of the Steering Group for the Department of Health Familial Hypercholesterolaemia Cascade Testing Audit Project


1 Institute of Child Health, London IDEAS Genetics Knowledge Park, UCL, 30 Guilford Street, London WC1N 1EH; 2 London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT; 3 The Royal Oldham Hospital, The Pennine Acute Hospitals NHS Trust, Rochdale Road, Oldham OL1 2JH; 4 The Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Edgbaston, Birmingham B15 2TH; 5 Royal Bournemouth Hospital, The Royal Bournemouth and Christchurch Hospitals NHS Trust, Castle Lane East, Bournemouth BH7 7DW; 6 Royal Surrey County Hospital, Royal Surrey County Hospital NHS Trust, Egerton Road, Guildford, Surrey GU2 7XX; 7 Heart of England NHS Foundation Trust, Birmingham B9 5SS; 8 Nottingham University Hospitals NHS Trust, City Campus, Hucknall Road, Nottingham NG5 1PB; 9 Royal Albert Edward Infirmary, Wrightington, Wigan and Leigh NHS Trust, Wigan Lane, Wigan WN1 2NN; 10 Hope Hospital, Salford Royal Hospitals NHS Trust, Stott Lane, Salford M6 8HD; 11 Trafford General Hospital, Trafford Healthcare NHS Trust, Moorside Road, Davyhulme, Manchester M41 5SL; 12 Frimley Park Hospital NHS Foundation Trust, Portsmouth Road, Frimley, Surrey GU16 7UJ; 13 Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, London WC1E 6JJ, UK


Corresponding author: Prof S E Humphries. Email: rmhaseh{at}ucl.ac.uk


Background: Family tracing is a method recognized to find new patients with familial hypercholesterolaemia (FH). We have implemented family tracing led by FH Nurses and have determined acceptability to patients, feasibility and costs.

Methods: Nurses were located at five National Health Service (NHS) Trusts; they identified FH patients and offered them family tracing. Responses and test results were recorded on a database and summarized on a family pedigree.

Results: The majority (~70%) of index cases participated; the proportion was lower when patients had been discharged from the clinics and in metropolitan areas. On average, 34% (range 13–50%) of relatives lived outside the catchment area of the clinics and could not attend the nurse-led FH clinics. Of the previously untested relatives, 76% who lived in the catchment area of the clinic came forward to be tested. One-third of the relatives who came forward for testing were children ≤16 y of age. The proportion of relatives diagnosed as likely to have FH was lower than would be predicted (30% vs. 50%). This was mainly due to the uncertainty of a diagnosis based on lipid measurements. The average cost to identify and test one relative was approximately £500 but was higher in the metropolitan areas.

Conclusion: Cascade testing for FH in the UK is feasible, acceptable and likely to be cost-effective if it is a routine aspect of clinical care. However, national implementation would require an integrated infrastructure, so that all individuals have access to testing, and specialist services for the management of young people.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
A. I Bima, A. J Hooper, F. M van Bockxmeer, and J. R Burnett
Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia
Ann Clin Biochem, September 1, 2009; 46(5): 420 - 422.
[Abstract] [Full Text] [PDF]



Acute CT - A Primer of Emergency Imaging